Suppr超能文献

相似文献

1
Optimizing patient selection for focal therapy-mapping and ablating the index lesion.
Transl Androl Urol. 2018 Sep;7(Suppl 4):S519-S525. doi: 10.21037/tau.2018.03.16.
2
Re: Value of three-dimensional US for optimizing guidance for ablating focal liver tumors.
J Vasc Interv Radiol. 2002 Feb;13(2 Pt 1):216. doi: 10.1016/s1051-0443(07)61945-9.
3
Magnetic electroanatomical mapping for ablation of focal atrial tachycardias.
Pacing Clin Electrophysiol. 1998 Aug;21(8):1621-35. doi: 10.1111/j.1540-8159.1998.tb00252.x.
4
Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Eur Radiol. 2018 Oct;28(10):4281-4287. doi: 10.1007/s00330-018-5409-z. Epub 2018 Apr 25.
5
How to select the right patients for focal therapy of prostate cancer?
Curr Opin Urol. 2014 May;24(3):203-8. doi: 10.1097/MOU.0000000000000045.
8
Evaluating localized prostate cancer and identifying candidates for focal therapy.
Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.
9
A nonfluoroscopic catheter-based mapping technique to ablate focal ventricular tachycardia.
Pacing Clin Electrophysiol. 1998 Jul;21(7):1442-7. doi: 10.1111/j.1540-8159.1998.tb00216.x.

引用本文的文献

1
MRI after focal therapy for prostate cancer: what radiologists must know?
Abdom Radiol (NY). 2025 May;50(5):2201-2220. doi: 10.1007/s00261-024-04670-5. Epub 2024 Nov 15.
2
3
Magnetic resonance imaging of the prostate after focal therapy with high-intensity focused ultrasound.
Abdom Radiol (NY). 2020 Nov;45(11):3882-3895. doi: 10.1007/s00261-020-02577-5.

本文引用的文献

1
Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer.
Radiographics. 2018 Mar-Apr;38(2):437-449. doi: 10.1148/rg.2018170147. Epub 2018 Jan 26.
2
National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
J Urol. 2018 May;199(5):1196-1201. doi: 10.1016/j.juro.2017.12.049. Epub 2017 Dec 26.
3
Assessment of Needle Tip Deflection During Transrectal Guided Prostate Biopsy: Implications for Targeted Biopsies.
J Endourol. 2018 Mar;32(3):252-256. doi: 10.1089/end.2017.0694. Epub 2018 Jan 26.
4
The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.
Urology. 2018 Feb;112:121-125. doi: 10.1016/j.urology.2017.10.014. Epub 2017 Oct 20.
5
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
J Urol. 2018 Feb;199(2):453-458. doi: 10.1016/j.juro.2017.08.085. Epub 2017 Aug 19.
6
Multi-parametric MRI imaging of the prostate-implications for focal therapy.
Transl Androl Urol. 2017 Jun;6(3):453-463. doi: 10.21037/tau.2017.04.29.
7
Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation.
Transl Androl Urol. 2017 Jun;6(3):406-412. doi: 10.21037/tau.2017.03.50.
8
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
10
An update on focal therapy for prostate cancer.
Nat Rev Urol. 2016 Nov;13(11):641-653. doi: 10.1038/nrurol.2016.177. Epub 2016 Sep 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验